Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci176738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Richard N Bergman. Hauptthemen laut MEDLINE: Insulin Resistance, Insulin-Secreting Cells, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NIDDK NIH HHS
Zitieren
APA
Bergman, R. N. (2024). Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance. Journal of Clinical Investigation. https://doi.org/10.1172/jci176738
Vancouver
Bergman RN. Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance. Journal of Clinical Investigation. 2024. doi:10.1172/jci176738
BibTeX
@article{Bergman2024,
author = {Bergman, Richard N},
title = {Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci176738}
}
EUVIMED